Enhanced Group Inc. (GETTEX:K7J0) Financings

Enhanced Group Inc.

Financings

RaiseDate
Private placement of class A shares
Update: US$15M · US$7.11 a share · Oppenheimer & Co. Inc. +1
Dealers: Oppenheimer & Co. Inc. (lead), Canaccord Genuity LLC (co-lead)
Buyers: Apeiron (Enhanced's controlling stockholder; participates in the PIPE financing)
Insiders: Apeiron, Enhanced's controlling stockholder, participates in the PIPE financing; its participation was reviewed by a special committee of independent directors.
Use of proceeds: Growth of sporting, telehealth and performance products businesses, supporting DEAG's buy-and-build strategy and general corporate purposes
Nov 12, 2026
Private placement of pIPE equity
Tranche closed: US$50M raised · US$3.89 a share · Warrants at US$3.89 · Cantor
Dealers: Cantor (lead)
Buyers: Apeiron Investment Group ($20 million; lead investor); Maximilian Martin ($5 million)
Insiders: Led by Apeiron Investment Group, the family office of Co-Founder and Chairman Christian Angermayer ($20 million), with participation from Co-Founder and CEO Maximilian Martin ($5 million)
Use of proceeds: Path to operational profitability in 2027 and accelerating the buildout of its Performance Medicine platform
Jun 18, 2026

Read by 6ix AI from the company's releases